FDA Inspection 1336632 — Catalent Argentina S.A.I.C.
The FDA completed an inspection of Catalent Argentina S.A.I.C. on Nov 9, 2023 in Buenos Aires. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 9, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Buenos Aires (Argentina)
Additional details
Mutual Recognition Agreement (MRA)